Last updated: January 7, 2026
Sponsor: Massachusetts General Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Aids And Aids Related Infections
Hiv Infections
Hiv/aids
Treatment
ADELANTE
Clinical Study ID
NCT06274632
2023P001913
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Self-identify as Latino/Latina/Latinx/Hispanic; adults 18 years and over; with HIVinfection confirmed by standard laboratory results available in the medical record; 3 or more months from initial entry into care with a medical provider who canprescribe HIV antiretroviral treatment; receiving HIV primary care at JacksonMemorial Hospital or Thomas Street at Quentin Mease Health Center/Harris HealthSystem; and medical record evidence with last viral load (VL) indicating viralnon-suppression (HIV RNA ≥200 cpm) within 12 months prior to assessment ofeligibility, as it is typical for providers to obtain laboratories prior to a clinicvisit in preparation for counseling.
Exclusion
Exclusion Criteria:
- Lacks capacity to consent (measured by a validated screener), plans to move out ofthe county in the next 6 months, or currently participating in an HIV interventionstudy with ongoing follow-up.
Study Design
Total Participants: 250
Treatment Group(s): 1
Primary Treatment: ADELANTE
Phase:
Study Start date:
May 22, 2024
Estimated Completion Date:
February 28, 2027
Study Description
Connect with a study center
University of Miami
Miami, Florida 33146
United StatesSite Not Available
University of Miami
Miami 4164138, Florida 4155751 33146
United StatesActive - Recruiting
Baylor College of Medicine
Houston, Texas 77030
United StatesSite Not Available
Baylor College of Medicine
Houston 4699066, Texas 4736286 77030
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.